000000703912/312021Q1False00000070392021-01-012021-03-31xbrli:shares00000070392021-04-25iso4217:USD00000070392021-03-3100000070392020-12-310000007039trec:CARESActMember2021-03-310000007039trec:CARESActMember2020-12-31iso4217:USDxbrli:shares0000007039us-gaap:ProductMember2021-01-012021-03-310000007039us-gaap:ProductMember2020-01-012020-03-310000007039us-gaap:ServiceMember2021-01-012021-03-310000007039us-gaap:ServiceMember2020-01-012020-03-3100000070392020-01-012020-03-310000007039us-gaap:CommonStockMember2020-12-310000007039us-gaap:AdditionalPaidInCapitalMember2020-12-310000007039us-gaap:TreasuryStockMember2020-12-310000007039us-gaap:RetainedEarningsMember2020-12-310000007039us-gaap:ParentMember2020-12-310000007039us-gaap:NoncontrollingInterestMember2020-12-310000007039us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310000007039us-gaap:ParentMember2021-01-012021-03-310000007039us-gaap:CommonStockMember2021-01-012021-03-310000007039us-gaap:TreasuryStockMember2021-01-012021-03-310000007039us-gaap:RetainedEarningsMember2021-01-012021-03-310000007039us-gaap:CommonStockMember2021-03-310000007039us-gaap:AdditionalPaidInCapitalMember2021-03-310000007039us-gaap:TreasuryStockMember2021-03-310000007039us-gaap:RetainedEarningsMember2021-03-310000007039us-gaap:ParentMember2021-03-310000007039us-gaap:NoncontrollingInterestMember2021-03-310000007039us-gaap:CommonStockMember2019-12-310000007039us-gaap:AdditionalPaidInCapitalMember2019-12-310000007039us-gaap:TreasuryStockMember2019-12-310000007039us-gaap:RetainedEarningsMember2019-12-310000007039us-gaap:ParentMember2019-12-310000007039us-gaap:NoncontrollingInterestMember2019-12-3100000070392019-12-310000007039us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310000007039us-gaap:ParentMember2020-01-012020-03-310000007039us-gaap:CommonStockMember2020-01-012020-03-310000007039us-gaap:RetainedEarningsMember2020-01-012020-03-310000007039us-gaap:CommonStockMember2020-03-310000007039us-gaap:AdditionalPaidInCapitalMember2020-03-310000007039us-gaap:TreasuryStockMember2020-03-310000007039us-gaap:RetainedEarningsMember2020-03-310000007039us-gaap:ParentMember2020-03-310000007039us-gaap:NoncontrollingInterestMember2020-03-3100000070392020-03-31xbrli:pure0000007039trec:PiocheElyValleyMinesIncMember2021-03-310000007039trec:AmakMember2021-03-31trec:segmentiso4217:SAR0000007039trec:AmakMember2019-09-222019-09-220000007039trec:AmakMember2021-01-012021-03-310000007039trec:AmakMember2021-03-310000007039trec:AmakMember2020-09-280000007039trec:AmakMember2020-03-260000007039trec:AmakMember2020-03-262020-03-2600000070392020-03-262020-03-260000007039us-gaap:ForeignCountryMember2020-03-2600000070392020-09-300000007039trec:AmakMember2020-07-012020-09-3000000070392020-07-012020-09-300000007039us-gaap:ForeignCountryMembertrec:AmakMember2021-01-012021-03-310000007039trec:SaudiIndustrialDevelopmentFundLimitedGuaranteeMember2021-03-310000007039us-gaap:DiscontinuedOperationsDisposedOfBySaleMembertrec:InvestmentInAlMasaneAlKobraMiningCompanyAMAKMember2021-01-012021-03-310000007039us-gaap:DiscontinuedOperationsDisposedOfBySaleMembertrec:InvestmentInAlMasaneAlKobraMiningCompanyAMAKMember2020-01-012020-03-31iso4217:SARiso4217:USD0000007039trec:AmakMember2021-01-012021-03-310000007039trec:AmakMember2020-01-012020-03-310000007039trec:AmakMember2021-03-310000007039trec:AmakMember2020-12-310000007039trec:AmakMember2020-01-012020-03-310000007039us-gaap:OilAndGasPropertiesMember2021-03-310000007039us-gaap:OilAndGasPropertiesMember2020-12-310000007039trec:CatalystMember2021-03-310000007039trec:CatalystMember2020-12-310000007039us-gaap:LandMember2021-03-310000007039us-gaap:LandMember2020-12-310000007039us-gaap:MachineryAndEquipmentMember2021-03-310000007039us-gaap:MachineryAndEquipmentMember2020-12-310000007039us-gaap:ConstructionInProgressMember2021-03-310000007039us-gaap:ConstructionInProgressMember2020-12-310000007039us-gaap:CostOfSalesMember2021-01-012021-03-310000007039us-gaap:CostOfSalesMember2020-01-012020-03-310000007039us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-03-310000007039us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310000007039us-gaap:CustomerRelationshipsMember2021-03-310000007039us-gaap:NoncompeteAgreementsMember2021-03-310000007039us-gaap:LicensingAgreementsMember2021-03-310000007039us-gaap:DevelopedTechnologyRightsMember2021-03-310000007039us-gaap:CustomerRelationshipsMember2020-12-310000007039us-gaap:NoncompeteAgreementsMember2020-12-310000007039us-gaap:LicensingAgreementsMember2020-12-310000007039us-gaap:DevelopedTechnologyRightsMember2020-12-310000007039us-gaap:StateAndLocalJurisdictionMember2021-03-310000007039us-gaap:StateAndLocalJurisdictionMember2020-12-310000007039us-gaap:ForeignCountryMember2021-03-310000007039us-gaap:ForeignCountryMember2020-12-310000007039us-gaap:RevolvingCreditFacilityMember2021-03-310000007039trec:TermLoanMember2021-03-310000007039us-gaap:RevolvingCreditFacilityMembertrec:AmendedAndRestatedCreditAgreementFourthAmendmentMember2021-03-310000007039trec:AmendedAndRestatedCreditAgreementFourthAmendmentMemberus-gaap:SubsequentEventMember2021-05-030000007039trec:TOCCOMembertrec:AmendedAndRestatedCreditAgreementFourthAmendmentMember2021-03-310000007039trec:TOCCOMembertrec:AmendedAndRestatedCreditAgreementFourthAmendmentMember2020-12-310000007039trec:TOCCOMembertrec:AmendedAndRestatedCreditAgreementFourthAmendmentMember2021-01-012021-03-310000007039trec:TOCCOMembertrec:AmendedAndRestatedCreditAgreementFourthAmendmentMember2020-01-012020-12-310000007039trec:SBALoansMembertrec:CARESActMember2020-05-062020-05-060000007039trec:SBALoansMembertrec:CARESActMember2020-05-060000007039trec:AmendedAndRestatedCreditAgreementFourthAmendmentMember2021-03-310000007039us-gaap:RevolvingCreditFacilityMember2020-12-310000007039trec:AcquisitionTermLoanMember2021-03-310000007039trec:AcquisitionTermLoanMember2020-12-310000007039trec:StockOptionPlanForKeyEmployeesMember2008-07-310000007039trec:TrecoraResourcesStockAndIncentivePlanMember2021-03-310000007039trec:StockOptionPlanForKeyEmployeesMemberus-gaap:EmployeeStockOptionMember2021-01-012021-03-310000007039trec:StockOptionPlanForKeyEmployeesMembersrt:MinimumMemberus-gaap:EmployeeStockOptionMember2021-01-012021-03-310000007039trec:StockOptionPlanForKeyEmployeesMembersrt:MaximumMemberus-gaap:EmployeeStockOptionMember2021-01-012021-03-310000007039trec:StockOptionPlanForKeyEmployeesMembertrec:EmployeeStockOptionAndWarrantMember2021-01-012021-03-310000007039trec:StockOptionPlanForKeyEmployeesMembertrec:EmployeeStockOptionAndWarrantMember2020-01-012020-03-310000007039trec:StockOptionPlanForKeyEmployeesMembertrec:EmployeeStockOptionAndWarrantMember2020-12-310000007039trec:StockOptionPlanForKeyEmployeesMembertrec:EmployeeStockOptionAndWarrantMember2021-03-310000007039trec:StockOptionPlanForKeyEmployeesMemberus-gaap:CommonStockMemberus-gaap:EmployeeStockOptionMember2021-03-310000007039trec:StockOptionPlanForKeyEmployeesMemberus-gaap:EmployeeStockOptionMember2020-01-012020-03-310000007039us-gaap:RestrictedStockUnitsRSUMembertrec:TrecoraResourcesStockAndIncentivePlanMember2021-01-012021-03-310000007039us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-03-310000007039us-gaap:RestrictedStockUnitsRSUMember2020-12-310000007039us-gaap:RestrictedStockUnitsRSUMember2021-03-310000007039us-gaap:SubsequentEventMember2021-04-012021-04-300000007039us-gaap:OperatingSegmentsMembertrec:PetrochemicalSegmentMembertrec:ProductSalesMember2021-01-012021-03-310000007039trec:SpecialtyWaxSegmentMemberus-gaap:OperatingSegmentsMembertrec:ProductSalesMember2021-01-012021-03-310000007039trec:ProductSalesMemberus-gaap:CorporateNonSegmentMember2021-01-012021-03-310000007039srt:ConsolidationEliminationsMembertrec:ProductSalesMember2021-01-012021-03-310000007039trec:ProductSalesMember2021-01-012021-03-310000007039trec:ProcessingFeesMemberus-gaap:OperatingSegmentsMembertrec:PetrochemicalSegmentMember2021-01-012021-03-310000007039trec:ProcessingFeesMembertrec:SpecialtyWaxSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000007039trec:ProcessingFeesMemberus-gaap:CorporateNonSegmentMember2021-01-012021-03-310000007039trec:ProcessingFeesMembersrt:ConsolidationEliminationsMember2021-01-012021-03-310000007039trec:ProcessingFeesMember2021-01-012021-03-310000007039us-gaap:OperatingSegmentsMembertrec:PetrochemicalSegmentMember2021-01-012021-03-310000007039trec:SpecialtyWaxSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000007039us-gaap:CorporateNonSegmentMember2021-01-012021-03-310000007039srt:ConsolidationEliminationsMember2021-01-012021-03-310000007039us-gaap:OperatingSegmentsMembertrec:PetrochemicalSegmentMembertrec:ProductSalesMember2020-01-012020-03-310000007039trec:SpecialtyWaxSegmentMemberus-gaap:OperatingSegmentsMembertrec:ProductSalesMember2020-01-012020-03-310000007039trec:ProductSalesMemberus-gaap:CorporateNonSegmentMember2020-01-012020-03-310000007039srt:ConsolidationEliminationsMembertrec:ProductSalesMember2020-01-012020-03-310000007039trec:ProductSalesMember2020-01-012020-03-310000007039trec:ProcessingFeesMemberus-gaap:OperatingSegmentsMembertrec:PetrochemicalSegmentMember2020-01-012020-03-310000007039trec:ProcessingFeesMembertrec:SpecialtyWaxSegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000007039trec:ProcessingFeesMemberus-gaap:CorporateNonSegmentMember2020-01-012020-03-310000007039trec:ProcessingFeesMembersrt:ConsolidationEliminationsMember2020-01-012020-03-310000007039trec:ProcessingFeesMember2020-01-012020-03-310000007039us-gaap:OperatingSegmentsMembertrec:PetrochemicalSegmentMember2020-01-012020-03-310000007039trec:SpecialtyWaxSegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000007039us-gaap:CorporateNonSegmentMember2020-01-012020-03-310000007039srt:ConsolidationEliminationsMember2020-01-012020-03-310000007039us-gaap:OperatingSegmentsMembertrec:PetrochemicalSegmentMember2021-03-310000007039trec:SpecialtyWaxSegmentMemberus-gaap:OperatingSegmentsMember2021-03-310000007039us-gaap:CorporateNonSegmentMember2021-03-310000007039srt:ConsolidationEliminationsMember2021-03-310000007039us-gaap:OperatingSegmentsMembertrec:PetrochemicalSegmentMember2020-12-310000007039trec:SpecialtyWaxSegmentMemberus-gaap:OperatingSegmentsMember2020-12-310000007039us-gaap:CorporateNonSegmentMember2020-12-310000007039srt:ConsolidationEliminationsMember2020-12-31trec:executive0000007039us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMembersrt:ManagementMember2021-03-310000007039us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMembersrt:ManagementMember2020-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2021
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the transition period from _________ to __________
COMMISSION FILE NUMBER 1-33926
TRECORA RESOURCES
(Exact name of registrant as specified in its charter)
| | | | | |
Delaware | 75-1256622 |
(State or other jurisdiction of | (I.R.S. Employer Identification No.) |
incorporation or organization) | |
| | | | | | | | |
1650 Hwy 6 South, | Suite 190 | 77478 |
Sugar Land, | Texas |
(Address of principal executive offices) | (Zip code) |
Registrant's telephone number, including area code: (281) 980-5522
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock, par value $0.10 per share | TREC | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S–T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes X No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ Accelerated filer ☒
Non-accelerated filer ☐ Smaller reporting company ☒
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.____
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Number of shares of the Registrant's Common Stock (par value $0.10 per share) outstanding at April 25, 2021: 24,875,432.
TABLE OF CONTENTS
Item Number and Description
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS.
TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
| | | | | | | | | | | | | | |
| | March 31, 2021 (Unaudited) | | December 31, 2020 |
ASSETS | | (thousands of dollars, except par value) |
Current Assets | | | | |
Cash | | $ | 53,026 | | | $ | 55,664 | |
| | | | |
Trade receivables, net | | 25,929 | | | 25,301 | |
Inventories | | 11,739 | | | 12,945 | |
| | | | |
Prepaid expenses and other assets | | 6,392 | | | 9,198 | |
Taxes receivable | | 2,788 | | | 2,788 | |
Total current assets | | 99,874 | | | 105,896 | |
| | | | |
Property, plant and equipment, net | | 187,923 | | | 187,104 | |
| | | | |
| | | | |
Intangible assets, net | | 12,433 | | | 12,893 | |
Lease right-of-use assets, net | | 9,757 | | | 10,528 | |
Mineral properties in the United States | | 412 | | | 412 | |
| | | | |
TOTAL ASSETS | | $ | 310,399 | | | $ | 316,833 | |
| | | | |
LIABILITIES | | | | |
Current Liabilities | | | | |
Accounts payable | | $ | 16,584 | | | $ | 14,447 | |
Accrued liabilities | | 6,002 | | | 6,857 | |
| | | | |
Current portion of long-term debt | | 4,194 | | | 4,194 | |
Current portion of lease liabilities | | 3,219 | | | 3,195 | |
Current portion of other liabilities | | 639 | | | 891 | |
Total current liabilities | | 30,638 | | | 29,584 | |
| | | | |
CARES Act, PPP Loans | | 6,123 | | | 6,123 | |
Long-term debt, net of current portion | | 40,852 | | | 41,901 | |
Post-retirement benefit, net of current portion | | 319 | | | 320 | |
Lease liabilities, net of current portion | | 6,538 | | | 7,333 | |
Other liabilities, net of current portion | | 637 | | | 648 | |
Deferred income taxes | | 25,593 | | | 26,517 | |
Total liabilities | | 110,700 | | | 112,426 | |
| | | | |
COMMITMENTS AND CONTINGENCIES (Note 12) | | | | |
| | | | |
EQUITY | | | | |
Common stock - authorized 40 million shares of $0.10 par value; issued 25.0 million and 24.8 million and outstanding 24.9 million and 24.8 million in 2021 and 2020, respectively | | 2,490 | | | 2,483 | |
Additional paid-in capital | | 61,692 | | | 61,311 | |
Treasury stock, at cost (0.1 million shares) | | (692) | | | — | |
Retained earnings | | 135,920 | | | 140,324 | |
Total Trecora Resources Stockholders' Equity | | 199,410 | | | 204,118 | |
Non-controlling Interest | | 289 | | | 289 | |
Total equity | | 199,699 | | | 204,407 | |
| | | | |
TOTAL LIABILITIES AND EQUITY | | $ | 310,399 | | | $ | 316,833 | |
See notes to consolidated financial statements.
TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
| | | | | | | | | | | | | | | |
| THREE MONTHS ENDED MARCH 31, | | |
| 2021 | | 2020 | | | | |
| (thousands of dollars, except per share amounts) |
REVENUES | | | | | | | |
Product sales | $ | 51,565 | | | $ | 57,183 | | | | | |
Processing fees | 3,020 | | | 4,884 | | | | | |
| 54,585 | | | 62,067 | | | | | |
| | | | | | | |
OPERATING COSTS AND EXPENSES | | | | | | | |
Cost of sales and processing (including depreciation and amortization of $4,055 and $3,952, respectively) | 52,240 | | | 53,989 | | | | | |
| | | | | | | |
GROSS PROFIT | 2,345 | | | 8,078 | | | | | |
| | | | | | | |
GENERAL AND ADMINISTRATIVE EXPENSES | | | | | | | |
General and administrative | 7,332 | | | 6,674 | | | | | |
Depreciation | 226 | | | 216 | | | | | |
| 7,558 | | | 6,890 | | | | | |
| | | | | | | |
OPERATING INCOME (LOSS) | (5,213) | | | 1,188 | | | | | |
| | | | | | | |
OTHER INCOME (EXPENSE) | | | | | | | |
| | | | | | | |
Interest expense | (302) | | | (916) | | | | | |
| | | | | | | |
Miscellaneous income (expense), net | 110 | | | (62) | | | | | |
| (192) | | | (978) | | | | | |
| | | | | | | |
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES | (5,405) | | | 210 | | | | | |
| | | | | | | |
INCOME TAX BENEFIT | 1,001 | | | 5,653 | | | | | |
| | | | | | | |
INCOME (LOSS) FROM CONTINUING OPERATIONS | (4,404) | | | 5,863 | | | | | |
| | | | | | | |
INCOME FROM DISCONTINUED OPERATIONS, NET OF TAX | — | | | 4,857 | | | | | |
| | | | | | | |
NET INCOME (LOSS) | $ | (4,404) | | | $ | 10,720 | | | | | |
| | | | | | | |
Basic Earnings (Loss) per Common Share | | | | | | | |
Net income (loss) from continuing operations (dollars) | $ | (0.18) | | | $ | 0.24 | | | | | |
Net income from discontinued operations, net of tax (dollars) | — | | | 0.20 | | | | | |
Net income (loss) (dollars) | $ | (0.18) | | | $ | 0.44 | | | | | |
| | | | | | | |
Basic weighted average number of common shares outstanding | 24,861 | | | 24,765 | | | | | |
| | | | | | | |
Diluted Earnings (Loss) per Common Share | | | | | | | |
Net income (loss) from continuing operations (dollars) | $ | (0.18) | | | $ | 0.23 | | | | | |
Net income from discontinued operations, net of tax (dollars) | — | | | 0.19 | | | | | |
Net income (loss) (dollars) | $ | (0.18) | | | $ | 0.42 | | | | | |
| | | | | | | |
Diluted weighted average number of common shares outstanding | 24,861 | | | 25,276 | | | | | |
See notes to consolidated financial statements.
TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)
THREE MONTHS ENDED MARCH 31
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | TRECORA RESOURCES STOCKHOLDERS | | | | |
| | COMMON STOCK | | ADDITIONAL PAID-IN | | TREASURY | | RETAINED | | | | NON- CONTROLLING | | TOTAL |
| | SHARES | | AMOUNT | | CAPITAL | | STOCK | | EARNINGS | | TOTAL | | INTEREST | | EQUITY |
| | (thousands) | | (thousands of dollars) |
December 31, 2020 | | 24,833 | | | $ | 2,483 | | | $ | 61,311 | | | $ | — | | | $ | 140,324 | | | $ | 204,118 | | | $ | 289 | | | $ | 204,407 | |
| | | | | | | | | | | | | | | | |
Restricted Stock Units | | | | | | | | | | | | | | | | |
Issued to Directors | | — | | | — | | | 113 | | | — | | | — | | | 113 | | | — | | | 113 | |
Issued to Employees | | — | | | — | | | 275 | | | — | | | — | | | 275 | | | — | | | 275 | |
Common Stock | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Issued to Employees | | 61 | | | 7 | | | (7) | | | — | | | — | | | — | | | — | | | — | |
Stock Repurchases | | — | | | — | | | — | | | (692) | | | — | | | (692) | | | — | | | (692) | |
Net Loss | | — | | | — | | | — | | | — | | | (4,404) | | | (4,404) | | | — | | | (4,404) | |
| | | | | | | | | | | | | | | | |
March 31, 2021 | | 24,894 | | | $ | 2,490 | | | $ | 61,692 | | | $ | (692) | | | $ | 135,920 | | | $ | 199,410 | | | $ | 289 | | | $ | 199,699 | |
| | | | | | | | | | | | | | | | |
December 31, 2019 | | 24,750 | | | $ | 2,475 | | | $ | 59,530 | | | $ | — | | | $ | 109,149 | | | $ | 171,154 | | | $ | 289 | | | $ | 171,443 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Restricted Stock Units | | | | | | | | | | | | | | | | |
Issued to Directors | | — | | | — | | | 94 | | | — | | | — | | | 94 | | | — | | | 94 | |
Issued to Employees | | — | | | — | | | 259 | | | — | | | — | | | 259 | | | — | | | 259 | |
Common Stock | | | | | | | | | | | | | | | | |
Issued to Directors | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
Issued to Employees | | 30 | | | 3 | | | (3) | | | — | | | — | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Net Income | | — | | | — | | | — | | | — | | | 10,720 | | | 10,720 | | | — | | | 10,720 | |
| | | | | | | | | | | | | | | | |
March 31, 2020 | | 24,780 | | | $ | 2,478 | | | $ | 59,880 | | | $ | — | | | $ | 119,869 | | | $ | 182,227 | | | $ | 289 | | | $ | 182,516 | |
See notes to consolidated financial statements.
TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
| | | | | | | | | | | | | | |
| | THREE MONTHS ENDED MARCH 31, |
| | 2021 | | 2020 |
| | (thousands of dollars) |
OPERATING ACTIVITIES | | | | |
Net Income (Loss) | | $ | (4,404) | | | $ | 10,720 | |
Income from Discontinued Operations | | — | | | 4,857 | |
Income (Loss) from Continuing Operations | | $ | (4,404) | | | $ | 5,863 | |
Adjustments to Reconcile Income (Loss) from Continuing Operations To Net Cash Provided by Operating Activities: | | | | |
Depreciation and Amortization | | 3,820 | | | 3,492 | |
Amortization of Intangible Assets | | 461 | | | 461 | |
| | | | |
Stock-based Compensation | | 571 | | | 390 | |
Deferred Income Taxes | | (924) | | | 10,385 | |
Postretirement Obligation | | (6) | | | 10 | |
| | | | |
Amortization of Loan Fees | | 45 | | | 45 | |
(Gain) Loss on Disposal of Assets | | (254) | | | 18 | |
Changes in Operating Assets and Liabilities: | | | | |
Increase in Trade Receivables | | (628) | | | (2,077) | |
Decrease in Insurance Receivables | | — | | | 274 | |
Increase in Taxes Receivable | | — | | | (16,144) | |
Decrease in Inventories | | 1,206 | | | 5,263 | |
Decrease in Prepaid Expenses and Other Assets | | 2,803 | | | 185 | |
Increase (Decrease) in Accounts Payable and Accrued Liabilities | | 1,282 | | | (3,739) | |
Decrease in Other Liabilities | | (141) | | | (72) | |
Net Cash Provided by Operating Activities - Continuing Operations | | 3,831 | | | 4,354 | |
Net Cash Used in Operating Activities - Discontinued Operations | | — | | | (53) | |
Net Cash Provided by Operating Activities | | 3,831 | | | 4,301 | |
INVESTING ACTIVITIES | | | | |
Additions to Property, Plant and Equipment | | (4,781) | | | (2,065) | |
Proceeds from Sale of Property, Plant and Equipment | | 281 | | | — | |
Net Cash Used in Investing Activities - Continuing Operations | | (4,500) | | | (2,065) | |
Net Cash Provided by Investing Activities - Discontinued Operations | | — | | | 10,163 | |
Net Cash Provided by (Used in) Investing Activities | | (4,500) | | | 8,098 | |
FINANCING ACTIVITIES | | | | |
Repurchase of Common Stock | | (692) | | | — | |
Net Cash Paid Related to Stock-Based Compensation | | (183) | | | — | |
| | | | |
Additions to Long-Term Debt | | — | | | 20,000 | |
Repayments of Long-Term Debt | | (1,094) | | | (1,094) | |
Net Cash (Used in) Provided by Financing Activities - Continuing Operations | | (1,969) | | | 18,906 | |
NET (DECREASE) INCREASE IN CASH | | (2,638) | | | 31,305 | |
CASH AT BEGINNING OF PERIOD | | 55,664 | | | 6,145 | |
CASH AT END OF PERIOD | | $ | 53,026 | | | $ | 37,450 | |
Supplemental disclosure of cash flow information: | | |
Cash payments for interest | | $ | 257 | | | $ | 870 | |
| | | | |
Supplemental disclosure of non-cash items: | | | | |
Capital expansion amortized to depreciation expense | | $ | 116 | | | $ | 262 | |
| | | | |
Foreign taxes paid by AMAK | | $ | 1,054 | | | $ | — | |
| | | | |
See notes to consolidated financial statements.
TRECORA RESOURCES AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
1. GENERAL
Organization
Trecora Resources (the “Company”) was incorporated in the State of Delaware in 1967. The Company's principal business activities are the manufacturing of various specialty petrochemical products, specialty waxes and providing custom processing services.
The Company’s specialty petrochemicals operations are primarily conducted through its wholly-owned subsidiary, Texas Oil and Chemical Co. II, Inc. (“TOCCO”). TOCCO owns all of the capital stock of South Hampton Resources, Inc. (“SHR”) and Trecora Chemical, Inc. (“TC”). SHR owns all of the capital stock of Gulf State Pipe Line Company, Inc. (“GSPL”). SHR owns and operates a specialty petrochemicals product facility in Silsbee, Texas which manufactures high purity hydrocarbons used primarily in polyethylene, packaging, polypropylene, expandable polystyrene, poly-iso/urethane foams, Canadian tar sands, and in the catalyst support industry. TC owns and operates a facility located in Pasadena, Texas which manufactures specialty waxes and provides custom processing services. These specialty waxes are used in the production of coatings, hot melt adhesives and lubricants. GSPL owns and operates pipelines that connect the SHR facility to a natural gas line, to SHR’s truck and rail loading terminal and to a major petroleum pipeline owned by an unaffiliated third party.
The Company owns approximately 55% of the capital stock of a Nevada mining company, Pioche Ely Valley Mines, Inc. (“PEVM”), which does not conduct any substantial business activity but owns undeveloped properties in the United States.
The Company also previously owned 33% of a Saudi Arabian joint stock company, Al Masane Al Kobra Mining Company (“AMAK”). The final closing of the sale of our ownership interest in AMAK was completed on September 28, 2020. For more information, see Note 5.
For convenience in this report, the terms “Company”, “our”, “us”, “we” or “TREC” may be used to refer to Trecora Resources and its subsidiaries.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and in conformity with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these unaudited financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and, therefore, should be read in conjunction with the financial statements and related notes contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2020.
The unaudited condensed consolidated financial statements included in this document have been prepared on the same basis as the annual financial statements and in management's opinion reflect all adjustments, including normal recurring adjustments, necessary to present fairly the Company's financial position, results of operations and cash flows for the interim periods presented. We have made estimates and judgments affecting the amounts reported in this document. The actual results that we experience may differ materially from our estimates. In the opinion of management, the disclosures included in these financial statements are adequate to make the information presented not misleading.
Operating results for the three months ended March 31, 2021 are not necessarily indicative of results for the year ending December 31, 2021.
We currently operate in two segments, Specialty Petrochemicals and Specialty Waxes. All revenue originates from sources in the United States, and all long-lived assets owned are located in the United States.
In addition, on September 28, 2020, we completed the final closing of the sale of our ownership interest in AMAK, a Saudi Arabian closed joint stock company, which owns, operates and is developing mining assets in Saudi Arabia. Our investment was classified as held-for-sale and the equity in earnings (losses) are recorded in discontinued operations. See Note 5 for additional discussion.
2. RECENT ACCOUNTING PRONOUNCEMENTS
Recently Adopted Accounting Pronouncements
In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12), which simplifies the
accounting for income taxes. This guidance was effective for us in the first quarter of 2021. The adoption of this guidance did not have a material impact on our consolidated financial statements.
Recent Accounting Pronouncements Not Yet Adopted
In March 2020, the FASB issued ASU No. 2020–04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04), which provides guidance to alleviate the burden in accounting for reference rate reform by allowing certain expedients and exceptions in applying generally accepted accounting principles to contracts, hedging relationships, and other transactions impacted by reference rate reform. The provisions of ASU 2020-04 apply only to those transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. This guidance is effective from March 12, 2020 through December 31, 2022 and adoption is optional. We are currently evaluating the impact of ASU 2020-04 on our consolidated financial statements.
3. TRADE RECEIVABLES
| | | | | | | | | | | | | | |
Trade receivables, net consisted of the following: | | | | |
| | March 31, 2021 | | December 31, 2020 |
| | (thousands of dollars) |
Trade receivables | | $ | 26,229 | | | $ | 25,601 | |
Less allowance for doubtful accounts | | (300) | | | (300) | |
Total trade receivables, net | | $ | 25,929 | | | $ | 25,301 | |
Trade receivables serve as collateral for our amended and restated credit agreement. See Note 11.
4. INVENTORIES
| | | | | | | | | | | | | | |
Inventories consisted of the following: | | | | |
| | March 31, 2021 | | December 31, 2020 |
| | (thousands of dollars) |
Raw material | | $ | 1,592 | | | $ | 2,580 | |
Work in process | | 171 | | | 138 | |
Finished products | | 9,976 | | | 10,227 | |
Total inventories | | $ | 11,739 | | | $ | 12,945 | |
Inventory serves as collateral for our amended and restated credit agreement. See Note 11.
Inventory included Specialty Petrochemicals products in transit valued at approximately $2.5 million and $3.6 million at March 31, 2021 and December 31, 2020, respectively.
5. INVESTMENT IN AMAK AND DISCONTINUED OPERATIONS
On September 28, 2020, the Company completed the final closing of the previously disclosed sale of its ownership interest in AMAK (the “Share Sale”) to AMAK and certain existing shareholders of AMAK and their assignees (collectively, the “Purchasers”). The Share Sale was completed in multiple closings pursuant to a Share Sale and Purchase Agreement, dated September 22, 2019 (which we refer to herein as the “Purchase Agreement”), among the Company, AMAK, and other Purchasers and resulted in aggregate gross proceeds to the Company of Saudi Riyals (“SAR”) 265 million (approximately $70 million) (before taxes and expenses).
As a condition to the effectiveness of the Purchase Agreement, the Purchasers advanced 5% of the purchase price (or approximately $3.5 million) in the form of a non-refundable deposit. Pursuant to the Purchase Agreement, (i) with respect to any Purchaser that completed the purchase of all or a portion of the ordinary shares allotted to it under the Purchase Agreement on or before March 31, 2020, the non-refundable deposit paid by such Purchaser (or a portion of such deposit for a partial closing) was credited toward the purchase price of the ordinary shares being purchased and (ii) with respect to any Purchasers that completed the purchase of all or a portion of their allotted ordinary shares after March 31, 2020 but on or before September 28, 2020, an amount equal to 50% of the non-refundable deposit paid by such Purchasers was forfeited to the Company as liquidated damages and such amount was not applied to the purchase price paid by the applicable Purchaser.
On March 26, 2020, the Company and one Purchaser completed the first closing of the Share Sale (the “First Closing”). In connection with the First Closing, the Company sold 4,000,000 ordinary shares for aggregate gross proceeds (before taxes and transaction expenses) of SAR 40 million (or approximately $10.7 million) (inclusive of the full amount of the
Purchaser’s non-refundable deposit previously paid of $0.5 million). The Company recorded a foreign tax payable of approximately $0.3 million related to the First Closing.
During the third quarter of 2020, the Company completed additional closings of the Share Sale with respect to its remaining ownership interest in AMAK. In connection with these closings, the Company sold a total of 22,467,422 ordinary shares for aggregate gross proceeds (before taxes and transaction expenses) of SAR 224 million (or approximately $59.9 million) (inclusive of $1.5 million which constituted 50% of the non-refundable deposits previously paid by certain Purchasers). As none of the third quarter 2020 closings were completed prior to March 31, 2020, the remaining portion of the initial deposits (approximately $1.5 million) were forfeited to the Company as liquidated damages and were not applied to the purchase price. These amounts are included in income from discontinued operations, net of tax. The Company recorded a foreign tax payable of approximately $1.1 million related to the third quarter 2020 closings.
In connection with the completion of the Share Sale, the Company and AMAK entered into an agreement whereby AMAK agreed to withhold approximately $2.1 million of the purchase price to pay the Company’s estimated tax obligations in Saudi Arabia. The Company is in the process of finalizing the necessary tax returns in the Kingdom of Saudi Arabia. All foreign taxes paid will create foreign tax credit to offset U.S. taxes. As of March 31, 2021, approximately $1.3 million of foreign taxes has been paid. The remaining funds of approximately $0.8 million withheld by AMAK are included in prepaid expenses and other assets on the Company’s consolidated balance sheets as of March 31, 2021.
As previously disclosed, and as a result of the Company’s investment in AMAK, the Company was required to execute a limited guarantee on October 24, 2010 (the “Guarantee”) of up to 41% of a loan (the “Loan”) by the Saudi Industrial Development Fund (“SIDF”) to AMAK to fund the construction of the AMAK facilities and to provide working capital needs. The provision of personal or corporate guarantees, as applicable, by each shareholder of AMAK was a condition to SIDF providing the Loan. Pursuant to the Purchase Agreement, the Purchasers (other than AMAK) agreed, upon the completion of the Share Sale, to assume the Company’s obligation under the Guarantee (proportionately based upon such Purchaser’s percentage acquisition of ordinary shares in the Share Sale). While a formal written release of the Company from the Guarantee was not obtained from SIDF prior to closing, the Company believes that the Purchasers’ assumption of the Company’s obligation under the Guarantee effectively eliminates the Company’s liability arising under the Guarantee.
Included in discontinued operations are the following:
| | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2021 | | 2020 | | | | |
| | (thousands of dollars) | | |
Saudi administration and transaction expenses | | $ | — | | | $ | 17 | | | | | |
Equity in losses of AMAK | | — | | | (532) | | | | | |
Gain on sale of equity interest | | — | | | 6,663 | | | | | |
Income from discontinued operations before taxes | | — | | | 6,148 | | | | | |
Tax expense | | — | | | (1,291) | | | | | |
Income from discontinued operations, net of tax | | $ | — | | | $ | 4,857 | | | | | |
AMAK's financial statements were prepared in the functional currency of AMAK which is the SAR. In June 1986, the SAR was officially pegged to the U. S. Dollar at a fixed exchange rate of 1 USD to 3.75 SAR.
The summarized results of operations and financial position for AMAK are as follows:
Results of Operations
| | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2021 | | 2020 | | | | |
| | (thousands of dollars) | | |
Sales | | $ | — | | | $ | 17,937 | | | | | |
Cost of sales | | — | | | 16,821 | | | | | |
Gross profit | | — | | | 1,116 | | | | | |
Selling, general, and administrative | | — | | | 2,680 | | | | | |
Operating income (loss) | | — | | | (1,564) | | | | | |
Other income | | — | | | 17 | | | | | |
Finance and interest expense | | — | | | (531) | | | | | |
Income (loss) before Zakat and income taxes | | — | | | (2,078) | | | | | |
Zakat and income tax (benefit) | | — | | | 533 | | | | | |
Net Income (Loss) | | $ | — | | | $ | (2,611) | | | | | |
Financial Position
| | | | | | | | | | | | | | |
| | March 31, | | December 31, |
| | 2021 | | 2020 |
| | (thousands of dollars) |
Current assets | | $ | — | | | $ | 29,799 | |
Noncurrent assets | | — | | | 209,814 | |
Total assets | | $ | — | | | $ | 239,613 | |
| | | | |
Current liabilities | | $ | — | | | $ | 40,919 | |
Long term liabilities | | — | | | 79,122 | |
Stockholders' equity | | — | | | 119,572 | |
| | $ | — | | | $ | 239,613 | |
The equity in the earnings (losses) of AMAK included in income (loss) from discontinued operations, net of tax, on the condensed consolidated statements of operations for the three months ended March 31, 2021 and 2020, is comprised of the following:
| | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2021 | | 2020 | | | | |
| | (thousands of dollars) | | |
AMAK Net Loss | | — | | | (2,611) | | | | | |
| | | | | | | | |
| | | | | | | | |
Company's share of loss reported by AMAK | | — | | | (869) | | * | | | |
Amortization of difference between Company's investment in AMAK and Company's share of net assets of AMAK | | — | | | 337 | | | | | |
Equity in losses of AMAK | | — | | | (532) | | | | | |
* Percentage of Ownership varies during the period. |
For additional information, see NOTE 6, “INVESTMENT IN AMAK AND DISCONTINUED OPERATIONS” to the consolidated financial statements set forth in our Annual Report on Form 10–K for the year ended December 31, 2020.
6. PREPAID EXPENSES AND OTHER ASSETS
| | | | | | | | | | | | | | |
Prepaid expenses and other assets consisted of the following: | | | | |
| | March 31, 2021 | | December 31, 2020 |
| | (thousands of dollars) |
Prepaid license | | $ | 202 | | | $ | 403 | |
Prepaid insurance premiums | | 2,767 | | | 4,241 | |
Spare parts | | 1,944 | | | 2,376 | |
| | | | |
Cash held in escrow by AMAK | | 823 | | | 1,877 | |
Other prepaid expenses and assets | | 656 | | | 301 | |
Total prepaid expenses and other assets | | $ | 6,392 | | | $ | 9,198 | |
7. PROPERTY, PLANT AND EQUIPMENT
| | | | | | | | | | | | | | |
Property, plant and equipment consisted of the following: | | | | |
| | March 31, 2021 | | December 31, 2020 |
| | (thousands of dollars) |
Platinum catalyst metal | | $ | 1,580 | | | $ | 1,580 | |
Catalyst | | 4,298 | | | 4,325 | |
Land | | 5,428 | | | 5,428 | |
Plant, pipeline and equipment | | 271,960 | | | 270,149 | |
Construction in progress | | 9,335 | | | 6,422 | |
Total property, plant and equipment | | $ | 292,601 | | | $ | 287,904 | |
Less accumulated depreciation | | (104,678) | | | (100,800) | |
Total property, plant and equipment, net | | $ | 187,923 | | | $ | 187,104 | |
Property, plant and equipment serve as collateral for our amended and restated credit agreement. See Note 11.
Labor capitalized for construction was approximately $0.3 million and $0.6 million for the three months ended March 31, 2021 and 2020, respectively.
Construction in progress during the first three months of 2021 included costs for rebuild and restoration of a distillation tower. Construction in progress during the first three months of 2020 included Advanced Reformer unit improvements and pipeline maintenance at SHR and equipment modifications at TC.
Amortization relating to the catalyst, which is included in cost of sales, was approximately $0.3 million and $0.2 million for the three months ended March 31, 2021 and 2020, respectively.
8. LEASES
The Company leases certain rail cars, rail equipment, office space and office equipment. The Company determines if a contract is a lease at the inception of the arrangement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and accounts for these options when they are reasonably certain of being exercised.
Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets. Lease expense for these leases is recognized on a straight-line basis over the lease term.
The Company has no finance leases.
| | | | | | | | | | | | | | | | | | |
The components of lease expense were as follows: | | | | | | | |
($ in thousands) | Classification in the Condensed Consolidated Statements of Income | Three Months Ended March 31, | | |
2021 | | 2020 | | | | |
Operating lease cost (a) | Cost of sales, exclusive of depreciation and amortization | $ | 1,049 | | | $ | 920 | | | | | |
Operating lease cost (a) | Selling, general and administrative | 34 | | | 48 | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Total lease cost | | $ | 1,083 | | | $ | 968 | | | | | |
(a) Short-term lease costs were approximately $0.2 million and $0.1 million for the three months ended March 31, 2021 and 2020, respectively.
The Company had no variable lease expense, as defined by ASC 842, during the periods.
| | | | | | | | | | | | | | |
($ in thousands) | Classification on the Condensed Consolidated Balance Sheets | March 31, 2021 | | December 31, 2020 |
Assets: | | | | |
Operating | Operating lease assets | $ | 9,757 | | | $ | 10,528 | |
| | | | |
Total lease right-of-use assets, net | | $ | 9,757 | | | $ | 10,528 | |
| | | | |
Liabilities: | | | | |
Current: | | | | |
Operating | Current portion of operating lease liabilities | $ | 3,219 | | | $ | 3,195 | |
| | | | |
Noncurrent: | | | | |
Operating | Operating lease liabilities | 6,538 | | | 7,333 | |
| | | | |
Total lease liabilities | | $ | 9,757 | | | $ | 10,528 | |
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
($ in thousands) | 2021 | | 2020 | | | | |
Cash paid for amounts included in the measurement of lease liabilities: | | | | | | | |
Operating cash flows used for operating leases | $ | 903 | | | $ | 947 | | | | | |
| | | | | | | |
| | | | | | | |
Right-of-use assets obtained in exchange for lease obligations: | | | | | | | |
Operating leases | $ | 19 | | | $ | — | | | | | |
| | | | | | | |
| | | | | | | | | | | |
| March 31, 2021 | | March 31, 2020 |
Weighted-average remaining lease term (in years): | | | |
Operating leases | 3.5 | | 4.3 |
| | | |
Weighted-average discount rate: | | | |
Operating leases | 4.5 | % | | 4.5 | % |
| | | |
Most of the Company’s lease contracts do not provide a readily determinable implicit rate. For these contracts, the Company’s estimated incremental borrowing rate is based on information available at the inception of the lease.
| | | | | | | |
As of March 31, 2021, maturities of lease liabilities were as follows: | | | |
($ in thousands) | Operating Leases | | |
2021 | $ | 2,691 | | | |
2022 | 3,273 | | | |
2023 | 2,380 | | | |
2024 | 1,066 | | | |
2025 | 995 | | | |
Thereafter | 118 | | | |
Total lease payments | $ | 10,523 | | | |
Less: Interest | 766 | | | |
Total lease obligations | $ | 9,757 | | | |
9. INTANGIBLE ASSETS, NET
Intangible assets were recorded in relation to the acquisition of TC on October 1, 2014.
| | | | | | | | | | | | | | | | | | | | |
The following tables summarize the gross carrying amounts and accumulated amortization of intangible assets by major class: |
| | March 31, 2021 |
| | Gross | | Accumulated Amortization | | Net |
| | (thousands of dollars) |
Customer relationships | | $ | 16,852 | | | $ | (7,302) | | | $ | 9,550 | |
Non-compete agreements | | 94 | | | (94) | | | — | |
Licenses and permits | | 1,471 | | | (734) | | | 737 | |
Developed technology | | 6,131 | | | (3,985) | | | 2,146 | |
Total | | $ | 24,548 | | | $ | (12,115) | | | $ | 12,433 | |
| | | | | | | | | | | | | | | | | | | | |
| | December 31, 2020 |
| | Gross | | Accumulated Amortization | | Net |
| | (thousands of dollars) |
Customer relationships | | $ | 16,852 | | | $ | (7,022) | | | $ | 9,830 | |
Non-compete agreements | | 94 | | | (94) | | | — | |
Licenses and permits | | 1,471 | | | (707) | | | 764 | |
Developed technology | | 6,131 | | | (3,832) | | | 2,299 | |
Total | | $ | 24,548 | | | $ | (11,655) | | | $ | 12,893 | |
Amortization expense for intangible assets included in cost of sales was approximately $0.5 million and $0.5 million for the three months ended March 31, 2021 and 2020, respectively.
Based on identified intangible assets that are subject to amortization as of March 31, 2021, we expect future amortization expenses for each period to be as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Total | | Remainder of 2021 | | 2022 | | 2023 | | 2024 | | 2025 | | 2026 | | Thereafter |
| | (thousands of dollars) |
Customer relationships | | $ | 9,550 | | | $ | 843 | | | $ | 1,123 | | | $ | 1,123 | | | 1,123 | | | 1,123 | | | 1,123 | | | $ | 3,092 | |
| | | | | | | | | | | | | | | | |
Licenses and permits | | 737 | | | 74 | | | 86 | | | 86 | | | 86 | | | 86 | | | 86 | | | 233 | |
Developed technology | | 2,146 | | | 460 | | | 613 | | | 613 | | | 460 | | | — | | | — | | | — | |
Total future amortization expense | | $ | 12,433 | | | $ | 1,377 | | | $ | 1,822 | | | $ | 1,822 | | | $ | 1,669 | | | $ | 1,209 | | | $ | 1,209 | | | $ | 3,325 | |
10. ACCRUED LIABILITIES
| | | | | | | | | | | | | | |
Accrued liabilities consisted of the following: | | | | |
| | March 31, 2021 | | December 31, 2020 |
| | (thousands of dollars) |
State taxes | | $ | 45 | | | $ | 125 | |
Property taxes | | 906 | | | — | |
Payroll | | 2,104 | | | 2,282 | |
Royalties | | 391 | | | 260 | |
Officer compensation | | 368 | | | 1,053 | |
| | | | |
Foreign taxes | | — | | | 1,054 | |
AMAK transaction costs | | — | | | 559 | |
Other | | 2,188 | | | 1,524 | |
Total accrued liabilities | | $ | 6,002 | | | $ | 6,857 | |
11. LIABILITIES AND LONG-TERM DEBT
Senior Secured Credit Facilities
As of March 31, 2021, the Company had no outstanding borrowings under the senior secured revolving credit facility (the “Revolving Facility”) and approximately $45.0 million in borrowings outstanding under the senior secured term loan facility (the “Term Loan Facility”) (and, together with the Revolving Facility, the “Credit Facilities”), in each case, under the Company's amended and restated credit agreement (as amended, the “ARC Agreement”). In addition, the Company had approximately $53 million of availability under our Revolving Facility at March 31, 2021. TOCCO’s ability to make additional borrowings under the Revolving Facility at March 31, 2021 was limited by, and in the future may be limited by, the Company's obligation to maintain compliance with the covenants contained in the ARC Agreement (including maintenance of a maximum Consolidated Leverage Ratio and minimum Consolidated Fixed Charge Coverage Ratio (each as defined in the ARC Agreement)).
On May 3, 2021, TOCCO, SHR, GSPL and TC (SHR, GSPL and TC collectively, the "Guarantors") entered into an Eighth Amendment to Amended and Restated Credit Agreement (the “Eighth Amendment”) which amended the definition of Consolidated EBITDA for any Measurement Period (as defined in the ARC Agreement) (including any Measurement Period containing the quarter ended March 31, 2021) to allow for certain add backs not to exceed $5.0 million in the aggregate for the 2021 fiscal year related to charges, expenses and losses arising from or related to the prolonged period of sub-freezing temperatures and snow across the State of Texas and the region in February 2021 (the “Texas freeze event”).
For each fiscal quarter after December 31, 2019, TOCCO must maintain a maximum Consolidated Leverage Ratio of 3.50 to 1.00 (subject to temporary increase following certain acquisitions). TOCCO's Consolidated Leverage Ratio was 1.62 and 1.65 as of March 31, 2021 and December 31, 2020, respectively. Additionally, TOCCO must maintain a minimum Consolidated Fixed Charge Coverage Ratio as of the end of any fiscal quarter of 1.15 to 1.00. TOCCO's Consolidated Fixed Charge Coverage Ratio was 2.13 and 1.80 as of March 31, 2021 and December 31, 2020, respectively.
The maturity date for the ARC Agreement is July 31, 2023. As of March 31, 2021, the year to date effective interest rate for the Credit Facilities was 1.88%. The ARC Agreement contains a number of customary affirmative and negative covenants and the Company was in compliance with those covenants as of March 31, 2021.
For a summary of additional terms of the Credit Facilities, see NOTE 13, “LONG-TERM DEBT AND LONG-TERM OBLIGATIONS” to the consolidated financial statements set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2020.
PPP Loans
On May 6, 2020, SHR and TC (collectively, the “Borrowers”) received loan proceeds from loans (the “PPP Loans”) under the United States Small Business Administration Paycheck Protection Program in an aggregate principal amount of approximately $6.1 million. The PPP Loans are evidenced by unsecured promissory notes each payable to Bank of America, N.A. The Borrowers fully utilized the PPP Loans to cover payroll and benefits costs in accordance with the relevant terms and conditions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loans mature on May 6, 2022, and bear interest at a stated rate of 1.0% per annum. The Company is currently working on the forgiveness applications and expects to receive full forgiveness of the PPP Loans in accordance with the provisions of the CARES Act.
Debt Issuance Costs
Debt issuance costs of approximately $0.9 million were incurred in connection with the fourth amendment to the ARC Agreement in July 2018. Unamortized debt issuance costs of approximately $0.4 million and $0.5 million for the periods ended March 31, 2021 and December 31, 2020, have been netted against outstanding loan balances.
| | | | | | | | | | | |
Long-term debt and long-term obligations are summarized as follows: | | | |
| March 31, 2021 | | December 31, 2020 |
| (thousands of dollars) |
Revolving Facility | $ | — | | | $ | — | |
Term Loan Facility | 45,469 | | | 46,563 | |
| | | |
Loan fees | (423) | | | (468) | |
Total long-term debt | 45,046 | | | 46,095 | |
Less current portion including loan fees | 4,194 | | | 4,194 | |
Total long-term debt, less current portion including loan fees | $ | 40,852 | | | $ | 41,901 | |
12. COMMITMENTS AND CONTINGENCIES
Litigation
The Company is periodically named in legal actions arising from normal business activities. We evaluate the merits of these actions and, if we determine that an unfavorable outcome is probable and can be reasonably estimated, we will establish the necessary reserves. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.
Supplier Agreements
In accordance with our supplier agreements, on a recurring monthly basis, the Company commits to purchasing a determined volume of feedstock in anticipation of upcoming requirements. Feedstock purchases are invoiced and recorded when they are delivered. As of March 31, 2021 and December 31, 2020, the value of the remaining undelivered feedstock approximated $14.2 million and $9.2 million, respectively.
From time to time, we may incur shortfall fees due to feedstock purchases being below the minimum amounts prescribed by our agreements with our suppliers. Shortfall fee expenses were approximately $0.4 million and $0.3 million for the three months ended March 31, 2021 and 2020, respectively.
Environmental Remediation
Amounts charged to expense for various activities related to environmental monitoring, compliance, and improvements were approximately $0.3 million and $0.2 million for the three months ended March 31, 2021 and 2020, respectively.
13. STOCKHOLDERS' EQUITY
In March 2021, The Company’s Board of Directors authorized the repurchase of up to $20 million in common stock by March 2023 (the “Share Repurchase Program”). The share repurchases will be executed from time to time on the open market, through privately negotiated transactions or through broker-negotiated purchases, in compliance with applicable securities law. The timing and amount of any shares of the Company’s stock that are repurchased under the Share Repurchase Program will be determined by the Company’s management based on its evaluation of market conditions and other factors, including the Company’s stock price, although the Share Repurchase Program may be suspended or discontinued at any time. In connection with the Share Repurchase Program, the Company deposited funds with a broker to facilitate the repurchases. During the three months ended March 31, 2021, the Company repurchased 87,758 shares for $0.7 million.
14. STOCK-BASED COMPENSATION
The Stock Option Plan for Key Employees, as well as, the Non-Employee Director Stock Option Plan (hereinafter collectively referred to as the “Stock Option Plans”), were approved by the Company’s stockholders in July 2008. The Stock Option Plans allot for the issuance of up to 1,000,000 shares.
The Trecora Resources Stock and Incentive Plan (the “Plan”) was approved by the Company’s stockholders in June 2012. As amended, the Plan allots for the issuance of up to 2.5 million shares in the form of stock options or restricted stock unit awards.
The Company recognized stock-based compensation expense of approximately $0.6 million and $0.4 million for the three months ended March 31, 2021 and 2020, respectively.
Stock Options and Warrant Awards
Stock options and warrants granted under the provisions of the Stock Option Plans permit the purchase of our common stock at exercise prices equal to the closing price of Company common stock on the date the options were granted. The options have terms of 10 years and generally vest ratably over terms of 4 to 5 years. There were no stock options or warrant awards issued during the three months ended March 31, 2021 or 2020, respectively.
A summary of the status of the Company’s stock option and warrant awards is as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Stock Options and Warrants | | Weighted Average Exercise Price Per Share | | Weighted Average Remaining Contractual Life | | Intrinsic Value (in thousands) |
Outstanding at January 1, 2020 | 487,000 | | | 10.87 | | | | | |
Granted | — | | | — | | | | | |
Exercised | (20,000) | | | 4.09 | | | | | |
Forfeited | — | | | — | | | | | |
Outstanding at March 31, 2021 | 467,000 | | | 11.16 | | | 2.6 | | $ | — | |
Expected to vest | — | | | | | | | $ | — | |
Exercisable at March 31, 2021 | 467,000 | | | 11.16 | | | 2.6 | | $ | — | |
The aggregate intrinsic value of options was calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock. At March 31, 2021, options to purchase approximately 0.1 million shares of common stock were in-the-money.
Since no options were granted, the weighted average grant-date fair value per share of options granted during the three months ended March 31, 2021 and 2020, respectively, was zero.
The Company has no non-vested outstanding options as of March 31, 2021.
Restricted Stock Unit Awards
Generally, restricted stock unit awards are granted annually to officers and directors of the Company under the provisions of the Plan. Restricted stock units are also granted ad hoc to attract or retain key personnel, and the terms and conditions under which these restricted stock units vest vary by award. The fair market value of restricted stock units granted is equal to the Company’s closing stock price on the date of grant. Restricted stock units granted generally vest ratably over 3 years. Certain awards also include vesting provisions based on performance metrics measured over a 3 year period. Upon vesting, the restricted stock units are settled by issuing one share of Company common stock per unit.
| | | | | | | | | | | |
A summary of the status of the Company's restricted stock units activity is as follows: |
| Shares of Restricted Stock Units | | Weighted Average Grant Date Price per Share |
Outstanding at January 1, 2020 | 567,563 | | | 7.39 | |
Granted | 265,183 | | | 7.12 | |
Forfeited | (74,280) | | | 8.38 | |
Vested | (80,318) | | | 7.21 | |
Outstanding at March 31, 2021 | 678,148 | | | 7.12 | |
Expected to vest | 678,148 | | | |
15. INCOME TAXES
We file an income tax return in the U.S. federal jurisdiction and a margin tax return in Texas. Previously, the Texas Comptroller selected the R&D credit calculations related to the 2014 and 2015 calendar years for audit. The state of Texas suspended examination of the 2014 and 2015 calendar years in order to perform a comprehensive review of audit procedures to provide consistency. During the fourth quarter of 2019, we received notice that Texas had completed review of its procedures and initiated additional requests for information which has been submitted for their review. In February 2020, we received notice from the Internal Revenue Service (“IRS”) regarding the IRS's selection of the Company for an income tax
audit for the tax period ending December 31, 2017. We do not expect any material changes related to the federal or Texas audits. Our federal and Texas tax returns remain open for examination for the years 2016 through 2019. As of March 31, 2021 and December 31, 2020, respectively, we recognized no adjustments for uncertain tax positions or related interest and penalties.
The effective tax rate varies from the federal statutory rate of 21%, primarily as a result of state tax expense, stock based compensation, foreign taxes and a research and development credit for the three months ended March 31, 2021 and 2020. We continue to maintain a valuation allowance against certain deferred tax assets, specifically for mining claims for PEVM, where realization is not certain.
The CARES Act provided stimulus measures to companies impacted by the COVID-19 pandemic, which included the ability to defer payment for employer payroll taxes, utilize net operating loss (“NOL”) carrybacks, increased the limitation on the deductibility of interest expense, technical corrections to allow accelerated tax depreciation on qualified improvement property, as well as allowing qualified business to apply for loans and grants. We have filed carryback claims allowed under these provisions which are included in income tax receivable on the consolidated balance sheets.
In April 2021, we received approximately $2.5 million related to our second and final NOL carryback claims, including approximately $0.1 million of interest income.
16. SEGMENT INFORMATION
We operate through business segments according to the nature and economic characteristics of our products as well as the manner in which the information is used internally by our key decision maker, who is our Chief Executive Officer. Segment data may include rounding differences.
Our Specialty Petrochemicals segment includes SHR and GSPL. Our Specialty Waxes segment is TC. We also separately identify our corporate overhead which includes administrative activities such as legal, accounting, consulting, investor relations, officer and director compensation, corporate insurance, and other administrative costs.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2021 |
| Specialty Petrochemicals | | Specialty Waxes | | Corporate | | Eliminations | | Consolidated |
| (in thousands) |
Product sales | $ | 44,658 | | | $ | 6,907 | | | $ | — | | | $ | — | | | $ | 51,565 | |
Processing fees | 1,254 | | | 1,766 | | | — | | | — | | | 3,020 | |
Total revenues | 45,912 | | | 8,673 | | | — | | | — | | | 54,585 | |
Operating income (loss) before depreciation and amortization | 2,571 | | | (481) | | | (3,023) | | | — | | | (933) | |
Operating loss | (231) | | | (1,957) | | | (3,025) | | | — | | | (5,213) | |
Loss from continuing operations before taxes | (297) | | | (1,954) | | | (3,154) | | | — | | | (5,405) | |
Depreciation and amortization | 2,802 | | | 1,476 | | | 3 | | | — | | | 4,281 | |
Capital expenditures | 3,567 | | | 1,214 | | | — | | | — | | | 4,781 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2020 |
| Specialty Petrochemicals | | Specialty Waxes | | Corporate | | Eliminations | | Consolidated |
| (in thousands) |
Product sales | $ | 50,386 | | | $ | 6,797 | | | $ | — | | | — | | | $ | 57,183 | |
Processing fees | 1,244 | | | 3,640 | | | — | | | — | | | 4,884 | |
Total revenues | 51,630 | | | 10,437 | | | — | | | — | | | 62,067 | |
Operating income (loss) before depreciation and amortization | 6,490 | | | 1,066 | | | (2,415) | | | — | | | 5,141 | |
Operating income (loss) | 3,872 | | | (262) | | | (2,422) | | | — | | | 1,188 | |
Income (loss) from continuing operations before taxes | 2,942 | | | (242) | | | (2,490) | | | — | | | 210 | |
Depreciation and amortization | 2,617 | | | 1,328 | | | 7 | | | — | | | 3,952 | |
Capital expenditures | 1,601 | | | 316 | | | — | | | — | | | 1,917 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2021 |
| Specialty Petrochemicals | | Specialty Waxes | | Corporate | | Eliminations | | Consolidated |
| (in thousands) |
| | | | | | | | | |
| | | | | | | | | |
Intangible assets, net | — | | | 12,433 | | | — | | | — | | | 12,433 | |
Total assets | 285,549 | | | 81,194 | | | 124,744 | | | (181,088) | | | 310,399 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2020 |
| Specialty Petrochemicals | | Specialty Waxes | | Corporate | | Eliminations | | Consolidated |
| (in thousands) |
| | | | | | | | | |
| | | | | | | | | |
Intangible assets, net | — | | | 12,893 | | | — | | | — | | | 12,893 | |
Total assets | 298,198 | | | 83,108 | | | 127,260 | | | (191,733) | | | 316,833 | |
17. NET INCOME (LOSS) PER COMMON SHARE
The following tables set forth the computation of basic and diluted net income (loss) per share for the three months ended March 31, 2021 and 2020, respectively.
Net Income (Loss) per Common Share - Continuing Operations
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, 2021 | | Three Months Ended March 31, 2020 |
| | Loss | | Shares | | Per Share Amount | | Income | | Shares | | Per Share Amount |
| | (in thousands, except per share amounts) |
Basic: | | | | | | | | | | | | |
Net income (loss) from continuing operations | | $ | (4,404) | | | 24,861 | | | $ | (0.18) | | | $ | 5,863 | | | 24,765 | | | $ | 0.24 | |
Unvested restricted stock units | | | | — | | | | | | | 511 | | | |
| | | | | | | | | | | | |
Diluted: | | | | | | | | | | | | |
Net income (loss) from continuing operations | | $ | (4,404) | | | 24,861 | | | $ | (0.18) | | | $ | 5,863 | | | 25,276 | | | $ | 0.23 | |
Net Income (Loss) per Common Share - Discontinued Operations
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, 2021 | | Three Months Ended March 31, 2020 |
| | Loss | | Shares | | Per Share Amount | | Income | | Shares | | Per Share Amount |
| | (in thousands, except per share amounts) |
Basic: | | | | | | | | | | | | |
Net income from discontinued operations, net of tax | | $ | — | | | 24,861 | | | $ | — | | | $ | 4,857 | | | 24,765 | | | $ | 0.20 | |
Unvested restricted stock units | | | | — | | | | | | | 511 | | | |
| | | | | | | | | | | | |
Diluted: | | | | | | | | | | | | |
Net income from discontinued operations, net of tax | | $ | — | | | 24,861 | | | $ | — | | | $ | 4,857 | | | 25,276 | | | $ | 0.19 | |
Net Income (Loss) per Common Share
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, 2021 | | Three Months Ended March 31, 2020 |
| | Loss | | Shares | | Per Share Amount | | Income | | Shares | | Per Share Amount |
| | (in thousands, except per share amounts) |
Basic: | | | | | | | | | | | | |
Net income (loss) | | $ | (4,404) | | | 24,861 | | | $ | (0.18) | | | $ | 10,720 | | | 24,765 | | | $ | 0.44 | |
Unvested restricted stock units | | | | — | | | | | | | 511 | | | |
| | | | | | | | | | | | |
Diluted: | | | | | | | | | | | | |
Net income (loss) | | $ | (4,404) | | | 24,861 | | | $ | (0.18) | | | $ | 10,720 | | | 25,276 | | | $ | 0.42 | |
At March 31, 2021 and 2020, 0.5 million and 0.5 million shares of common stock, respectively, were issuable upon the exercise of options and warrants.
8. RELATED PARTY TRANSACTIONS
In November 2020, Company Director Adam C. Peakes joined Merichem Company as Executive Vice President and Chief Financial Officer. The Company incurred expenses of less than $0.1 million during the three months ended March 31, 2021 and 2020, respectively, for Merichem Company. At March 31, 2021 and December 31, 2020, we had outstanding liabilities payable to Merichem Company of less than $0.1 million and nil, respectively.
19. POST-RETIREMENT OBLIGATIONS
We currently have post-retirement obligations with two former executives. As of March 31, 2021 and December 31, 2020, approximately $0.3 million and $0.3 million, respectively, remained outstanding and was included in post-retirement obligations.
For additional information, see NOTE 22, “POST-RETIREMENT OBLIGATIONS” to the consolidated financial statements set forth in our Annual Report on Form 10–K for the year ended December 31, 2020.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
FORWARD LOOKING AND CAUTIONARY STATEMENTS
Some of the statements and information contained in this Quarterly Report on Form 10-Q may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements regarding the Company’s financial position, business strategy and plans and objectives of the Company’s management for future operations and other statements that are not historical facts, are forward-looking statements. Forward-looking statements are often characterized by the use of words such as “outlook,” “may,” “will,” “can,” “shall,” “should,” “could,” “expects,” “plans,” “anticipates,” “contemplates,” “proposes,” “believes,” “estimates,” “predicts,” “projects,” “potential,” “continue,” “intend,” or the negative of such terms and other comparable terminology, or by discussions of strategy, plans or intentions.
Forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other important factors that could cause the actual results, performance or our achievements, or industry results, to differ materially from historical results, any future results, or performance or achievements expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to the impacts of the COVID-19 pandemic on our business, financial results and financial condition and that of our customers, suppliers, and other counterparties; general economic and financial conditions domestically and internationally; insufficient cash flows from operating activities; our ability to attract and retain key employees; feedstock and product prices; feedstock availability and our ability to access third party transportation; competition; industry cycles; natural disasters or other severe weather events (including the Texas freeze event), health epidemics and pandemics (including the COVID-19 pandemic) and terrorist attacks; our ability to consummate extraordinary transactions, including acquisitions and dispositions, and realize the financial and strategic goals of such transactions; technological developments and our ability to maintain, expand and upgrade our facilities; regulatory changes; environmental matters; lawsuits; outstanding debt and other financial and legal obligations (including having to return the amounts borrowed under the PPP Loans or failing to qualify for forgiveness of such loans, in whole or in part); difficulties in obtaining additional financing on favorable conditions, or at all; local business risks in foreign countries, including civil unrest and military or political conflict, local regulatory and legal environments and foreign currency fluctuations; and other risks detailed in our latest Annual Report on Form 10-K, including, but not limited to, “Part I, Item 1A. Risk Factors” and “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” therein, under similar headings in this Quarterly Report on Form 10-Q and in our other filings with the Securities and Exchange Commission (the “SEC”). Many of these risks and uncertainties are currently amplified by and will continue to be amplified by, or in the future may be amplified by, the COVID-19 pandemic and other natural disasters such as severe weather events (including the Texas freeze event).
There may be other factors of which we are currently unaware or deem immaterial that may cause our actual results to differ materially from the forward-looking statements. In addition, to the extent any inconsistency or conflict exists between the information included in this report and the information included in our prior releases, reports and other filings with the SEC, the information contained in this report updates and supersedes such information.
Forward-looking statements are based on current plans, estimates, assumptions and projections, and, therefore, you should not place undue reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them in light of new information or future events.
Overview
The following discussion and analysis of our financial results, as well as the accompanying unaudited condensed consolidated financial statements and related notes to consolidated financial statements to which they refer, are the responsibility of our management. Our accounting and financial reporting fairly reflect our business model which is based on the manufacturing and marketing of specialty petrochemical products and waxes and providing custom manufacturing services.
The discussion and analysis of financial condition and the results of operations which appears below should be read in conjunction with “Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2020. These discussions of results reflect the continuing operations of the Company unless otherwise noted.
Our preferred supplier position into the specialty petrochemicals market is derived from the combination of our reputation as a reliable supplier established over many years, the very high purity of our products, and a focused approach to customer service. In specialty waxes, we are able to deliver to our customers a product performance and price point that is unique to our market; while the diversity of our custom processing assets and capabilities offers solutions to our customers that we believe are uncommon along the U.S. Gulf Coast.
Enabling our success in these businesses is a commitment to operational excellence which establishes a culture that prioritizes the safety of our employees and communities in which we operate, the integrity of our assets and regulatory compliance. This commitment drives a change to an emphasis on forward-looking, leading-indicators of our results and proactive steps to continuously improve our performance. We bring the same commitment to excellence to our commercial activities where we focus on the value proposition to our customers while understanding opportunities to maximize our value capture through service and product differentiation, supply chain and operating cost efficiencies and diversified supply options. We believe our focus on execution, meeting the needs of our customers, and growing our business while maintaining prudent control of our costs, will significantly contribute to enhanced shareholder value.
Review of First Quarter 2021 Results
We reported first quarter 2021 net loss from continuing operations of $4.4 million, down from net income from continuing operations of $5.9 million in the first quarter of 2020. During February 2021, a prolonged duration of sub-freezing temperatures and snow resulted in widespread utilities failures and rolling blackouts across the State of Texas and the region. This caused significant disruptions for our suppliers, customers and our own facilities. The Texas freeze event ultimately resulted in higher utility, repair and maintenance costs, as well as loss of sales at both facilities. Cost impacts of the Texas freeze event are estimated to be approximately $1.9 million across the Company, in addition to capital expenditures related to restoration of approximately $1.7 million. Sales volume of our Specialty Petrochemicals products decreased 12.9% in the first quarter of 2021 as compared to the first quarter of 2020. In addition, sales of Specialty Petrochemicals were also generally weaker compared to the same period last year due to the COVID-19 pandemic. Specialty Waxes sales revenue was up 1.6% compared to the first quarter 2020 due to wax feed supply interruptions in the first quarter of 2020.
Adjusted EBITDA from continuing operations was $(0.5) million for the first quarter of 2021, compared with Adjusted EBITDA from continuing operations of $5.5 million in the first quarter of 2020. Adjusted EBITDA from continuing operations decreased due to factors associated with the Texas freeze event in first quarter 2021, as noted above, which increased costs for the Company and our suppliers and also reduced demand for our products through its impact on our customers and their facilities. The Company estimates the impact of the Texas freeze event on Adjusted EBITDA in the first quarter of 2021 to be between $4.5 million and $5.0 million. Adjusted EBITDA from continuing operations is a non-GAAP financial measure. See below for additional information about this measure and a reconciliation to the most directly comparable GAAP financial measure.
COVID-19 Pandemic
The continued global impact of COVID-19 has resulted in various emergency measures to curb the spread of the virus. We continue to monitor the progression of the COVID-19 pandemic on a daily basis. Our guiding principle is, and has always been, the protection of our people and the communities in which we work, as well as maintaining the overall integrity of our assets. While our essential plant personnel remain on-site, many of our other employees continue to work remotely and socially distanced when in our offices. We are continuing to follow the orders and guidance of federal, state, and local governmental agencies, as we maintain our own stringent protocols in an effort to mitigate the spread of the virus and protect the health of our employees, customers, and suppliers as well as the communities in which we work. As an organization, we adopted social distancing behaviors early, executed the necessary changes to enable all possible job duties to be performed remotely and rapidly identified and executed the necessary adjustments to support optimal productivity for all remote workers.
To date, our plants have continued to operate as normal with regard to COVID-19, and our supply chain has generally remained intact, with adequate availability of raw materials. Importantly, under the U.S. Department of Homeland Security guidance issued on April 17, 2020 as updated through August 18, 2020, as well as many related state and local governmental orders, chemical manufacturing sites are considered essential critical infrastructure, and as such, are not currently subject to closure in the locations where we operate. Although there has been some disruption in global logistics channels, we have not experienced significant delays in fulfillment of customer orders.
The COVID-19 pandemic continues to have an impact on our business, results of operations, financial position and liquidity for the first quarter of 2021. In comparison to the same period in 2020, in the first quarter we continued to see reduced demand for our products and services which we attribute to the economic slowdown caused by the COVID-19 pandemic as well as to the Texas freeze event in February. This weakened demand may continue throughout 2021, and could spread more broadly to our other end markets.
Our management will continue to actively monitor the impact of the global pandemic on our business, results of operations, financial condition, liquidity, suppliers, industry, investments, and workforce. We do not currently anticipate any material impairments, with respect to intangible assets, long-lived assets, or right of use assets, increases in allowances for credit
losses from our customers, restructuring charges, other expenses, or changes in accounting judgments to have a material impact on our condensed consolidated financial statements.
On March 27, 2020, the CARES Act was signed into law to address the economic impact of the COVID-19 pandemic. On December 27, 2020, the Consolidated Appropriations Act, 2021 was signed into law and includes further relief and stimulus provisions to address economic concerns related to the COVID-19 pandemic. On March 11, 2021, the American Rescue Plan Act of 2021 was signed into law and provides further economic relief and stimulus to deal with the economic impact of the COVID-19 pandemic. We continue to monitor any effects that may result from these Acts and other similar legislation or actions on our Company.
Non-GAAP Financial Measures
We include in this Quarterly Report on Form 10-Q the non-GAAP financial measures of EBITDA from continuing operations and Adjusted EBITDA from continuing operations and provide reconciliations from our most directly comparable GAAP financial measures to those measures.
We believe these financial measures provide users of our financial statements with supplemental information that may be useful in evaluating our operating performance. We also believe that such non-GAAP measures, when read in conjunction with our operating results presented under GAAP, can be used to better assess our performance from period to period and relative to performance of other companies in our industry, without regard to financing methods, historical cost basis or capital structure. These measures are not measures of financial performance or liquidity under GAAP and should be considered in addition to, and not as a substitute for, analysis of our results under GAAP.
We define EBITDA from continuing operations as net income (loss) from continuing operations plus interest expense, income tax expense (benefit), depreciation and amortization. We define Adjusted EBITDA from continuing operations as EBITDA from continuing operations plus share-based compensation, plus restructuring and severance expenses, plus impairment losses and plus or minus gains or losses on disposal of assets.
The following table presents a reconciliation of net income (loss), our most directly comparable GAAP financial performance measure for each of the periods presented, to EBITDA from continuing operations and Adjusted EBITDA from continuing operations.
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2021 |
| Specialty Petrochemicals | | Specialty Waxes | | Corporate | | Consolidated |
| (in thousands) |
Net income (loss) | $ | 205 | | | $ | (1,954) | | | $ | (2,655) | | | $ | (4,404) | |
Income from discontinued operations, net of tax | — | | | — | | | — | | | — | |
Income (loss) from continuing operations | $ | 205 | | | $ | (1,954) | | | $ | (2,655) | | | $ | (4,404) | |
Interest expense | 302 | | | — | | | — | | | 302 | |
Income tax benefit | (486) | | | — | | | (515) | | | (1,001) | |
Depreciation and amortization | 200 | | | 23 | | | 3 | | | 226 | |
Depreciation and amortization in cost of sales | 2,602 | | | 1,452 | | | — | | | 4,054 | |
EBITDA from continuing operations | $ | 2,823 | | | $ | (479) | | | $ | (3,167) | | | $ | (823) | |
Stock-based compensation | — | | | — | | | 571 | | | 571 | |
Gain on disposal of assets | (254) | | | — | | | — | | | (254) | |
| | | | | | | |
| | | | | | | |
Adjusted EBITDA from continuing operations | $ | 2,569 | | | $ | (479) | | | $ | (2,596) | | | $ | (506) | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2020 |
| Specialty Petrochemicals | | Specialty Waxes | | Corporate | | Consolidated |
| (in thousands) |
Net income | $ | 4,596 | | | $ | 1,214 | | | $ | 4,910 | | | $ | 10,720 | |
Income from discontinued operations, net of tax | — | | | — | | | 4,857 | | | 4,857 | |
Income from continuing operations | $ | 4,596 | | | $ | 1,214 | | | $ | 53 | | | $ | 5,863 | |
Interest expense | 915 | | | — | | | 1 | | | 916 | |
Income tax benefit | (1,654) | | | (1,456) | | | (2,543) | | | (5,653) | |
Depreciation and amortization | 186 | | | 24 | | | 6 | | | 216 | |
Depreciation and amortization in cost of sales | 2,431 | | | 1,305 | | | — | | | 3,736 | |
EBITDA from continuing operations | $ | 6,474 | | | $ | 1,087 | | | $ | (2,483) | | | $ | 5,078 | |
Stock-based compensation | — | | | — | | | 390 | | | 390 | |
(Gain) loss on disposal of assets | (1) | | | 17 | | | — | | | 16 | |
| | | | | | | |
| | | | | | | |
Adjusted EBITDA from continuing operations | $ | 6,473 | | | $ | 1,104 | | | $ | (2,093) | | | $ | 5,484 | |
Liquidity and Capital Resources
Working Capital
Our approximate working capital days are summarized as follows:
| | | | | | | | | | | | | | | | | |
| March 31, 2021 | | December 31, 2020 | | March 31, 2020 |
Days sales outstanding in accounts receivable | 42.8 | | | 40.0 | | | 41.6 | |
Days sales outstanding in inventory | 19.4 | | | 20.5 | | | 12.3 | |
Days sales outstanding in accounts payable | 27.3 | | | 22.9 | | | 14.8 | |
Days of working capital | 34.8 | | | 37.7 | | | 39.1 | |
Our days sales outstanding in accounts receivable at March 31, 2021 was 42.8 days compared to 40 days at December 31, 2020. The increase was driven by higher selling prices during the first quarter of 2021. Our days sales outstanding in inventory decreased by approximately 1.1 days from December 31, 2020, driven primarily by lower production and the need to meet customer demands utilizing existing inventory. Our days sales outstanding in accounts payable increased primarily due to significant payables to our utilities suppliers driven by sharply higher rates for utilities in February 2021 due to the Texas freeze event. Since days of working capital is calculated using the above three metrics, it decreased for the aforementioned reasons discussed.
Our cash balance at March 31, 2021 was $53.0 million.
The change in cash is summarized as follows:
| | | | | | | | | | | | | | |
| | Three Months Ended March 31, |
| | 2021 | | 2020 |
Net cash provided by (used in) | | (thousands of dollars) |
Operating activities | | $ | 3,831 | | | $ | 4,301 | |
Investing activities | | (4,500) | | | 8,098 | |
Financing activities | | (1,969) | | | 18,906 | |
Increase (decrease) in cash | | $ | (2,638) | | | $ | 31,305 | |
Cash | | $ | 53,026 | | | $ | 37,450 | |
Operating Activities
Cash provided by operating activities totaled $3.8 million for the first three months of 2021, $0.5 million lower than the corresponding period in 2020. For the first three months of 2021, net income decreased by approximately $15.1 million as compared to the corresponding period in 2020. Major non-cash items affecting income in the first three months of 2021 included changes in depreciation and amortization of $4.3 million, deferred taxes of $(0.9) million, and stock-based compensation of $0.6 million. Major non-cash items affecting income in the first three months of 2020 included changes in depreciation and amortization of $4.0 million, deferred taxes of $10.4 million and stock-based compensation of $0.4 million.
Additional factors leading to the decrease in cash provided by operating activities included:
•Trade receivables increased approximately $0.6 million, primarily due to increases in selling prices. We do not expect any collection issues at this time.
•Inventories decreased approximately $1.2 million driven by planned reduction of inventory due to the successful turnaround at SHR combined with maintenance of customer demand through existing inventory during the Texas freeze event.
•Prepaid and other assets decreased $2.8 million primarily related to the payment of our foreign tax liability and amortization of our prepaid insurance for the quarter.
•Accounts payable and accrued liabilities increased $1.3 million primarily due to significant payables to our utilities suppliers driven by sharply higher rates for utilities in February 2021 due to the Texas freeze event.
Investing Activities
Cash used in investing activities during the first three months of 2021 was approximately $4.5 million, representing a decrease of approximately $12.6 million from the corresponding period of 2020. The primary outflow of the funds used in investing activities was additions and the rebuild and restoration of property, plant and equipment of approximately $4.8 million offset by proceeds from the sale of assets.
Financing Activities
Cash used in financing activities during the first three months of 2021 was approximately $2.0 million versus cash provided by financing activities of $18.9 million during the corresponding period of 2020. In the first quarter of 2021, we made a mandatory payment of $1.1 million on our Term Loan Facility and repurchased shares of our common stock under our Share Repurchase Program. During the first three months of 2020, we borrowed $20.0 million under the Revolving Facility for working capital purposes, offset by a mandatory payment on our Term Loan Facility.
Anticipated Cash Needs
As of March 31, 2021, we have approximately $53.0 million in cash, combined with an available balance on our Revolving Facility of approximately $53 million. As a result, we believe the Company is able to support its operating requirements and capital expenditures through internally generated funds supplemented with cash on our balance sheet and availability under our ARC Agreement.
Results of Operations
Comparison of Three Months Ended March 31, 2021 and 2020
Specialty Petrochemicals Segment
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, |
| | 2021 | | 2020 | | Change | | % Change |
| | (thousands of dollars) |
Product Sales | | $ | 44,658 | | | $ | 50,386 | | | $ | (5,728) | | | (11.4) | % |
Processing | | 1,254 | | | 1,244 | | | 10 | | | 0.8 | % |
Gross Revenue | | $ | 45,912 | | | $ | 51,630 | | | $ | (5,718) | | | (11.1) | % |
| | | | | | | | |
Volume of Sales (gallons) | | | | | | | | |
Specialty Petrochemicals Products | | 17,201 | | | 19,741 | | | (2,540) | | | (12.9) | % |
Prime Product Sales | | 14,675 | | | 16,218 | | | (1,543) | | | (9.5) | % |
By-product Sales | | 2,526 | | | 3,523 | | | (997) | | | (28.3) | % |
| | | | | | | | |
Cost of Sales | | $ | 42,869 | | | $ | 44,796 | | | (1,927) | | | (4.3) | % |
Gross Margin | | 6.6 | % | | 13.2 | % | | | | (6.6) | % |
Total Operating Expense* | | 20,357 | | | 16,740 | | | 3,617 | | | 21.6 | % |
Natural Gas Expense* | | 2,976 | | | 927 | | | 2,049 | | | 221.0 | % |
Operating Labor Costs* | | 3,348 | | | 4,005 | | | (657) | | | (16.4) | % |
Transportation Costs* | | 4,606 | | | 4,887 | | | (281) | | | (5.7) | % |
General & Administrative Expense | | 3,074 | | | 2,776 | | | 298 | | | 10.7 | % |
Depreciation and Amortization** | | 2,802 | | | 2,617 | | | 185 | | | 7.1 | % |
Capital Expenditures | | 3,567 | | | 1,601 | | | 1,966 | | | 122.8 | % |
* Included in cost of sales
**Includes $2,602 and $2,431 for 2021 and 2020, respectively, which is included in operating expense
Gross Revenue
Gross Revenue for our Specialty Petrochemicals segment decreased for the first quarter 2021 compared to the first quarter 2020 by 11.1%, primarily due to lower sales volumes for prime products and by-products which were impacted by the Texas freeze event in February 2021 as well as continued impact of the COVID-19 pandemic.
Product Sales
Specialty Petrochemicals segment product sales declined approximately 11.4% for the first quarter 2021 compared to the first quarter 2020. Prime products sales volume declined approximately 1.5 million gallons, or 9.5%, from the first quarter 2020 due to the Texas freeze event which resulted in widespread utilities failures and rolling blackouts across the state and region. This caused significant disruptions for our suppliers, customers and our own facilities. In addition, sales were also generally weaker compared to the same period last year due to the continued impact of the COVID-19 pandemic. By-product sales volumes in first quarter 2021 declined 28.3% compared to the first quarter 2020. By-products are produced as a result of prime product production and their margins are significantly lower than margins for our prime products. Foreign sales volume decreased to 17.8% of total Specialty Petrochemicals volume in the first quarter for 2021 compared to 22.8% in the first quarter 2020. Foreign sales volume includes sales to Canadian oil sands customers.
Processing
Processing revenues were $1.3 million in the first quarter 2021 compared to $1.2 million for the first quarter 2020.
Cost of Sales (includes but is not limited to raw materials and total operating expense)
We use natural gasoline as feedstock, which is the heavier liquid remaining after ethane, propane and butanes are removed from liquids produced by natural gas wells. The material is a commodity product in the oil/petrochemical markets and generally is readily available. The price of natural gasoline is highly correlated with the price of crude oil. Our Advanced Reformer unit upgrades the by-product stream produced as a result of prime product production. This upgrade allows us to sell our by-products at higher prices than would be possible without the Advanced Reformer unit.
Cost of sales declined by 4.3% for the first quarter 2021 compared to the first quarter 2020. The decline in cost of sales compared to the same period last year was driven by depressed sales volumes, offset by higher natural gas costs associated
with the Texas freeze event. Benchmark Mont Belvieu natural gasoline feedstock price increased by 42% from $0.93 per gallon in first quarter 2020 to $1.33 per gallon in the first quarter 2021. Despite the increase in feedstock costs, our margins for prime products were relatively flat in the first quarter of 2021 compared to first quarter of 2020. By-product margins were higher compared to the first quarter of 2020. This was primarily due to higher component prices.
The gross margin percentage for the Specialty Petrochemicals segment decreased from 13.2% for the first quarter of 2020 to 6.6% in the first quarter of 2021, primarily because of increased operating costs.
Total Operating Expense (includes but is not limited to natural gas, operating labor, depreciation and transportation)
Total Operating Expense increased $3.6 million, or 21.6%, for the first quarter 2021 compared to the same period in 2020, primarily due to higher natural gas costs and repair and maintenance costs associated with the Texas freeze event. Capital expenditures primarily relate to restoration costs associated with freezing weather in February 2021.
Capital Expenditures
Capital expenditures in the first quarter 2021 were approximately $3.6 million compared to $1.6 million in the first quarter of 2020. First quarter 2021 capital expenditures included approximately $0.8 million for rebuild and repair of a distillation tower, approximately $0.6 million for restoration costs associated with the damage to pipes and other plant equipment due to the Texas freeze event and approximately $0.8 million of continued work on the GSPL pipe line.
Specialty Waxes Segment
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, |
| | 2021 | | 2020 | | Change | | % Change |
| | (thousands of dollars) |
Product Sales | | $ | 6,907 | | | $ | 6,797 | | | $ | 110 | | | 1.6 | % |
Processing | | 1,766 | | | 3,640 | | | (1,874) | | | (51.5) | % |
Gross Revenue | | $ | 8,673 | | | $ | 10,437 | | | $ | (1,764) | | | (16.9) | % |
| | | | | | | | |
Volume of specialty wax sales (thousand pounds) | | 8,826 | | | 10,174 | | | (1,348) | | | (13.2) | % |
| | | | | | | | |
Cost of Sales | | $ | 9,321 | | | $ | 9,193 | | | $ | 128 | | | 1.4 | % |
Gross Margin (Loss) | | (7.5) | % | | 11.9 | % | | | | (19.4) | % |
General & Administrative Expense | | 1,235 | | | 1,483 | | | (248) | | | (16.7) | % |
Depreciation and Amortization* | | 1,476 | | | 1,328 | | | 148 | | | 11.1 | % |
Capital Expenditures | | $ | 1,214 | | | $ | 316 | | | $ | 898 | | | 284.2 | % |
*Includes $1,452 and $1,524 for 2021 and 2020, respectively, which is included in cost of sales
Product Sales
Product sales revenue for the Specialty Waxes segment increased by 1.6% for the first quarter of 2021 compared to the first quarter of 2020 due to higher selling prices. Specialty wax sales volume decreased nearly 1.3 million pounds in the first quarter of 2021 compared to the first quarter of 2020. Despite utilizing existing inventories, wax sales volumes in the first quarter of 2021 were depressed due to extended disruptions to feed supply and production limitations at our Pasadena facility resulting from the Texas freeze event. Our wax feed is based on certain by-products produced as a result of polyethylene production at major polyethylene producers' facilities on the US Gulf Coast.
Processing
Processing revenues were $1.8 million for the first quarter 2021, a $1.9 million decrease compared to the first quarter 2020, driven by lower demand resulting from the Texas freeze event in February 2021 and the resulting impacts on our customers.
Cost of sales
Cost of sales increased by 1.4%, or approximately $0.1 million, in the first quarter 2021 compared to the first quarter 2020. A reduction in force was completed in the first quarter of 2021 to improve the overall cost structure for the Specialty Waxes segment.
Depreciation
Depreciation for the first quarter 2021 was $1.5 million, a $0.1 million increase compared to the first quarter of 2020.
Capital Expenditures
Capital Expenditures were approximately $1.2 million in the first quarter 2021 compared to $0.3 million in the first quarter of 2020. Capital expenditures primarily relate to restoration costs associated with the damage to pipes and other plant equipment due to the Texas freeze event in February 2021.
Corporate Segment
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, |
| | 2021 | | 2020 | | Change | | % Change |
| | (thousands of dollars) | | |
General & Administrative Expense | | $ | 3,023 | | | $ | 2,415 | | | $ | 608 | | | 25.2 | % |
Corporate expenses increased $0.6 million in the first quarter of 2021 compared to the first quarter of 2020 primarily due to increases in consulting and insurance costs.
Investment in AMAK - Discontinued Operations
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, |
| | 2021 | | 2020 | | Change | | % Change |
| | (thousands of dollars) | | |
Equity in earnings (losses) of AMAK | | $ | — | | | $ | (532) | | | $ | 532 | | | 100.0 | % |
Equity in earnings (losses) of AMAK include amortization of the difference between the Company's investment in AMAK and the Company's share of net assets of AMAK.
We completed the sale of our ownership interest in AMAK during the third quarter of 2020. See Note 5 for additional discussion.
Contractual Obligations
Our contractual obligations are summarized in Part II, Item 7. “Management's Discussion and Analysis of Financial Condition and Results of Operations,” in our Annual Report on Form 10-K for the year ended December 31, 2020. There have been no other material changes to the contractual obligation amounts disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020.
Critical Accounting Policies and Estimates
Critical accounting policies are more fully described in Note 2, “RECENT ACCOUNTING PRONOUNCEMENTS” to the consolidated financial statements set forth in our Annual Report on Form 10-K for the year ended December 31, 2020. The preparation of consolidated financial statements in accordance with generally accepted accounting principles requires management to make estimates, assumptions and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the period reported. By their nature, these estimates, assumptions and judgments are subject to an inherent degree of uncertainty. We base our estimates, assumptions and judgments on historical experience, market trends and other factors that are believed to be reasonable under the circumstances. Estimates, assumptions and judgments are reviewed on an ongoing basis and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Actual results may differ from these estimates under different assumptions or conditions. Our critical accounting policies and estimates have been discussed with the Audit Committee of the Board of Directors and discussed in our Annual Report on Form 10-K for the year ended December 31, 2020. For the three months ended March 31, 2021, there were no significant changes to these policies.
Recent and New Accounting Standards
See Note 2 for a summary of recent accounting guidance.
Off Balance Sheet Arrangements
As of March 31, 2021, we do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on our financial statements, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
For quantitative and qualitative disclosure about market risk, see Part II, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk” in our Annual Report on Form 10–K for the year ended December 31, 2020. There have been no material changes in the Company's exposure to market risk from the disclosure included in such report.
ITEM 4. CONTROLS AND PROCEDURES.
(a)Evaluation of disclosure controls and procedures. Our Chief Executive Officer and Chief Financial Officer, with the participation of management, have evaluated the effectiveness of our “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15(d)-15(e) under the Securities Exchange Act of 1934) and determined that our disclosure controls and procedures were effective as of the end of the period covered by this report.
(b)Changes in internal control. There were no significant changes in our internal control over financial reporting that occurred during the three months ended March 31, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
The Company is periodically named in legal actions arising from normal business activities. The Company evaluates the merits of these actions and, if it determines that an unfavorable outcome is probable and can be reasonably estimated, the Company will establish the necessary reserves. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.
ITEM 1A. RISK FACTORS.
Readers of this Quarterly Report on Form 10–Q should carefully consider the risks described in the Company's other reports and filings filed with or furnished to the SEC, including the Company's prior and subsequent reports on Forms 10-K, 10-Q and 8-K, in connection with any evaluation of the Company's financial position, results of operations and cash flows.
The risks and uncertainties in the Company's most recent Annual Report on Form 10-K are not the only risks that the Company faces. Additional risks and uncertainties not presently known or those that are currently deemed immaterial may also affect the Company's operations. Any of the risks, uncertainties, events or circumstances described therein could cause the Company's future financial condition, results of operations or cash flows to be adversely affected. There have been no material changes from the risk factors previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2020.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
Issuer Purchases of Equity Securities
Please see the below table for information regarding repurchases of the Company’s common stock made by the Company during the period covered by this report.
| | | | | | | | | | | | | | | | | |
Period | (a) Total Number of Shares (or Units) Purchased(1) | (b) Average Price Paid Per Share (or Unit)(1) | | (c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs(2) | (d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs(2) |
January 1, 2021 - January 31, 2021 | — | | $ | — | | | — | | $ | — | |
February 1, 2021 - February 28, 2021 | 26,721 | | $ | 7.11 | | | — | | $ | — | |
March 1, 2021 - March 31, 2021 | 833 | | $ | 8.01 | | | 87,758 | | $ | 19,307,708 | |
Total | 27,554 | | $ | 7.14 | | | 87,758 | | $ | 19,307,708 | |
| | | | | |
(1) Represents shares of our common stock withheld for satisfaction of tax liabilities of a holder of restricted shares. The value of such shares was calculated based on the closing price of our common stock on the New York Stock Exchange (“NYSE”) on the date when the withholding was made. |
| | | | | |
(2) Represents shares of our common stock purchased on the open market pursuant to the Share Repurchase Program. The value of such shares was calculated based on the average purchase price of our common stock on the NYSE at the time the purchase was made. On March 1, 2021, the Company announced a repurchase program for up to $20 million of the Company's common stock, which will expire in March 2023. Repurchases under the Share Repurchase Program may be made at management's discretion from time to time on the open market, through privately negotiated transactions or through broker-negotiated purchases, in compliance with applicable securities law, including through a 10b5-1 Plan. The Company is not obligated to acquire any specific number of shares of our common stock under the Share Repurchase Program, which may be suspended for periods or discontinued at any time. The timing and the amount of any shares to be repurchased will be determined by management based on an evaluation of market conditions and other factors, including the Company’s stock price. |
ITEM 6. EXHIBITS.
The following documents are filed or incorporated by reference as exhibits to this Report. Exhibits marked with an asterisk (*) are filed herewith. Exhibits marked with a plus sign (+) are management contracts or a compensatory plan, contract or arrangement.
| | | | | |
Exhibit Number | Description |
10.1+* | |
10.2+* | |
10.3+* | |
10.4* | Eighth Amendment to Amended and Restated Credit Agreement, dated as of May 3, 2021, among Texas Oil & Chemical Co. II, Inc., as Borrower, certain subsidiaries of the Borrower, as Guarantors, the Lenders from time to time party thereto, Citibank, N.A., as an L/C Issuer, and Bank of America, N.A., as Administrative Agent, Swingline Lender and an L/C Issuer |
31.1* | |
31.2* | |
32.1* | |
32.2* | |
101.INS* | XBRL Instance Document (XBRL tags are embedded within the Inline XBRL document) |
101.SCH* | XBRL Taxonomy Schema Document |
101.CAL* | XBRL Taxonomy Calculation Linkbase Document |
101.LAB* | XBRL Taxonomy Label Linkbase Document |
101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document |
101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document |
104* | Cover Page Interactive Data File (formatted as inline XBRL and included as Exhibit 101) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | | |
| TRECORA RESOURCES |
| | |
Dated: May 6, 2021 | By: | /s/ Sami Ahmad |
| | Sami Ahmad |
| | Principal Financial Officer and Duly Authorized Officer |